Global law firm Greenberg Traurig, LLP hosted a series of events in its Boston office in conjunction with the 2025 BIO International Convention June 17-18. Designed for biotechnology, pharmaceutical, and medical technology leaders, these events offered timely legal insights, strategic networking, and innovation showcases.
On June 17, Greenberg Traurig hosted a luncheon seminar on “Building Your IP Strategy to Succeed in the U.S.” The session opened with welcome remarks by Koichiro Ohashi, co-chair of Greenberg Traurig’s Japan Practice, and Wayne H. Elowe, co-chair of the firm’s global Life Sciences & Medical Technology Group. Dr. Melissa Hunter-Ensor, co-chair of the firm’s Patents and Innovation Strategies Group, and David J. Dykeman, co-chair of the global Life Sciences & Medical Technology Group and co-managing shareholder of the Boston office, shared valuable insights about intellectual property (IP) strategy for life sciences companies looking to enter or expand in the U.S. market. Attendees learned how a strong IP strategy can drive company valuation, attract key investors and partners, and support long-term commercial success.
On the evening of June 17, the firm hosted a Life Sciences & MedTech Networking Reception attended by hundreds of life sciences executives, entrepreneurs, and investors.
On June 18, Greenberg Traurig hosted and sponsored Demo Day by HomeLab, a leading life sciences accelerator and residency program operated by LabFellows within the Center for Novel Therapeutics. The event spotlighted founders tackling the world’s biggest challenges with innovative novel therapeutics, artificial intelligence in biotech, sustainability/biomaterials, and tools & diagnostics representing top universities and research institutions. Dykeman, Shareholder Michael L. Hebert, Ph.D., and Associate Elena Rodriguez attended, connecting with emerging leaders and supporting groundbreaking innovation in life sciences.
About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from startups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig’s Boston Office: Greenberg Traurig’s Boston office is home to more than 100 attorneys practicing in the areas of banking and finance, corporate, emerging technology, energy, environmental, gaming, governmental affairs, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, real estate, restructuring and bankruptcy, tax, and white collar defense and investigations. An important contributor to the firm’s international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. Working collaboratively with the firm’s global network, the Boston team collectively offers clients decades of experience advising on complex legal matters and providing hands-on knowledge of the local business community.
About Greenberg Traurig: Greenberg Traurig, LLP has more than 2,850 attorneys across 49 locations in the United States, Europe, the Middle East, Latin America, and Asia. The firm’s broad geographic and practice range enables the delivery of innovative and strategic legal services across borders and industries. Recognized as a 2025 BTI “Best of the Best Recommended Law Firm” by general counsel for trust and relationship management, Greenberg Traurig is consistently ranked among the top firms on the Am Law Global 100, NLJ 500, and Law360 400. Greenberg Traurig is also known for its philanthropic giving, culture, innovation, and pro bono work. Web: www.gtlaw.com.